Mini-MBA in Drug Commercialization & Product Strategy
Mini-MBA in Drug Commercialization & Product Strategy
Online Certificate
With ever-changing market forces, political climates and regulatory changes, pharmaceutical business leaders are expected to do more with less, work easily across functions and always be ready for change.
From drug discovery through end-of-patent life, the Mini-MBA in Drug Commercialization & Product Strategy program exposes students to critical business, scientific and regulatory challenges leaders face at all stages of a product’s commercialization.
Duration:
12 weeks
Price:
$6,995
CEUs:
24
Partner:
Your Playbook to the Drug Commercialization Process
With a focus on disease prevention, customized treatments, digital therapeutics and the ripple effects of COVID-19 on healthcare, the pharma industry is changing at lightning speed. Pharma professionals need to navigate both the regulatory and business realities of the drug commercialization process and bridge the gap between scientific innovation and business goals in order to lead successful go-to-market strategies.
OpusVi™ and the University of Arizona’s Eller Executive Education have created the Mini-MBA in Drug Commercialization & Product Strategy to help you develop an understanding of pharmaceutical product development, commercialization and regulations as well as the business and management skills that you need to master the drug commercialization process from bench to bedside.
Three
leading pharma experts inform the program from start to finish to ensure relevancy and applicability.
Twelve
weeks of learning content teach key concepts from commercialization, positioning and forecasting, manufacturing and distribution, to timing strategies.
Two
Olympic gold medalists give insights into performing and persevering, even under pressure.
24 CEUs/CMEs
are awarded upon graduation, allowing nurses to meet their CE requirements
Get Insights on Overcoming Adversity in Pharmaceuticals
Not only is the pharma industry highly competitive, it is also highly regulated. As a result, many drugs and treatments never make it to the bedside. How can pharma leaders optimize their chances and lead a successful drug commercialization process — or keep their courage if a product has failed to make it to the bedside?
Learn more about overcoming setbacks from our Olympic success coaches: Dan O’Brien and Gail Devers. Both Dan and Gail had to overcome obstacles to win Olympic gold medals — now, they are sharing their insights on facing adversity in our Mini-MBA in Drug Commercialization & Product Strategy.
Organization Outcomes
- Elevate team effectiveness and achieve optimal organizational performance
- Empower organization leaders with strategic insights into the broad range of functional area engagement with pharmaceutical commercialization and brand management, including:
- General business strategy
- Market access
- Pharmaceutical science
- Legal environment/regulatory needs
- Marketing
- Market research
- Finance
- Operations management
Download our brochure.
The average manager spends 15 days chasing paperwork each year.
The traditional method for tracking & managing competencies doesn’t just lead to the big paper chase, it can result in unnecessary errors. Errors that will be caught on survey day. Errors that may be the difference between life and death.
It’s time to get One Step Ahead with our digital competency management program.
An organization of 50 employees can save 1,500 sq ft of storage space.*
*According to US Averages
About Eller Executive Education
Eller Executive Education is passionate about disrupting traditional executive education. By exploring the latest science in leadership development, modern business management theory, and contemporary learning design, they help organizations in over 93 global locations discover new ways to lead, manage, and innovate. Eller Executive Education is the fastest progressing executive education provider and holds a No. 5 ranking in the U.S. and No. 15 ranking globally for Customized Executive Education in the Financial Times Executive Education Ranking 2019.